当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-08-01 , DOI: 10.1056/nejmc2402341
Elisa Fabbrini 1 , Brian Rady 2 , Anastasiya Koshkina 1 , Jae Yoon Jeon 1 , Vivaswath S. Ayyar 2 , Cynthia Gargano 2 , Nicholas DiProspero 1 , Susan Wendel 1 , Julia Hegge 3 , Holly Hamilton 3 , Zhi-Ming Ding 3 , Maria Afrazi 3 , Anthony Nicholas 3 , Tao Pei 3 , Masayoshi Nakano 4 , Shohei Ouchi 4 , Yuki Saito 4 , Aimi Yamashita 4 , Ryo Tamamura 4 , Hernan Salazar 5 , Craig Shapiro 6 , Tatsuya Yoshihara 7 , Takuma Yonemura 8 , Satoshi Inoue 9 , Osamu Matsuoka 10 , Mark Erion 2 , Alessandro Pocai 2 , Hideo Makimura 1
Affiliation  

Homozygosity for the PNPLA3 risk allele is linked to liver fat accumulation. In phase 1 trials, JNJ-75220795, a hepatocyte-targeted GalNAc-conjugated PNPLA3 siRNA, reduced liver fat in PNPLA3 I148M...

中文翻译:


PNPLA3 siRNA 在 I148M 纯合子 MAFLD 患者中的 1 期试验



PNPLA3 风险等位基因的纯合性与肝脏脂肪积累有关。在 1 期试验中,JNJ-75220795(一种针对肝细胞的 GalNAc 缀合的 PNPLA3 siRNA)可减少 PNPLA3 I148M 中的肝脏脂肪...
更新日期:2024-08-02
down
wechat
bug